Thyroxine: Clinical Trials

158 trials of Thyroxine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

89 completed, 26 unknown, 12 recruiting, 10 not yet recruiting. 41 Phase 4, 39 Not applicable, 26 Phase 2, 25 Phase 3, 19 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 441Completed 18, Unknown 10, Terminated 5, Withdrawn 4, Not yet recruiting 2, Active not recruiting 1, Recruiting 1
Not applicable39Completed 19, Unknown 10, Recruiting 5, Not yet recruiting 2, Terminated 2, Enrolling by invitation 1
Phase 226Completed 17, Recruiting 3, Not yet recruiting 2, Active not recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 325Completed 15, Recruiting 3, Withdrawn 3, Not yet recruiting 2, Active not recruiting 1, Unknown 1
Phase 119Completed 16, Recruiting 1, Unknown 1, Withdrawn 1
Early Phase 13Completed 1, Not yet recruiting 1, Unknown 1

Follow Thyroxine: new trials by email Literature Review of Thyroxine trials Research Report on Thyroxine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Discontinuation of Low-Dose Levothyroxine in Older Adults With Subclinical Hypothyroidism
Levothyroxine Pill, Placebo - Hypothyroidism
Phase 4Not yet recruitingSpyridoula Maraka1382027-10-012026-08-26
COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer
Levothyroxine Oral Tablet [Synthroid] - Advanced Differentiated Thyroid Gland Carcinoma
Phase 2Not yet recruitingAHS Cancer Control Alberta702026-12-012026-02-06
T4/T3 Therapy in Hypothyroidism
Liothyronine (L-T3), Levothyroxine Sodium (LT4) Tablets, Liothyronine (LT3) placebo - Hypothyroidism Primary
Phase 2Not yet recruitingUniversity of Pennsylvania602026-11-012026-08-20
Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy
Euthyrox (levothyroxine), Cytomel (liothyronine) - Differentiated Thyroid Cancer, Thyroid Cancer
Not yet recruitingUniversity Medical Center Groningen402026-09-012026-02-10
Thyroxine Supplementation in Small for Gestational Age (SGA) Infants With Birth Weight <1500g and TSH 6-20 mIU/ml
Levothyroxine Sodium (LT4) Tablets - Thyroid Function, Preterm
Not applicableNot yet recruitingShandong Provincial Hospital1062026-06-202026-06-04
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Testosterone Enanthate, Testosterone Cypionate, Testosterone Propionate - Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
Not applicableEnrolling by invitationEnhanced Emirates Limited602026-03-122026-05-06
Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC
desiccated thyroid extract (DTE)+levothyroxine (L-T4) - Intermediate-to-High Risk Differentiated Thyroid Cancer
Phase 3Not yet recruitingWest China Hospital6462025-11-302025-11-20
Levothyroxine as Adjuvant to a Hypocaloric Diet for the Treatment of Obesity.
Levothyroxine, Placebo - Obesity
Phase 3RecruitingFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud2862025-11-052026-01-12
Levothyroxine Dosing in Neonatal Congenital Hypothyroidism
Levothyroxine - Congenital Hypothyroidism
Phase 4CompletedMenoufia University1012025-11-022026-08-10
Comparison of Two Timings of Levothyroxine Intake in Hypothyroid Patients: A Cross-over Randomized Control Trial
Levothyroxine Pill - Hypothyroidism Primary
Phase 4Active not recruitingElyes Kamoun1022025-07-242026-10-28
A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia
Antipsychotics plus Levothyroxine Sodium, Antipsychotics plus Placebo - Schizophrenia, Avolition
Early Phase 1Not yet recruitingPeking University902025-07-012025-06-10
Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.
Levothyroxin - Thyroid Cancer, Papillary Thyroid Carcinoma
Not applicableNot yet recruitingNational Cancer Center, Korea5782025-06-022025-05-14
LIGHT Trial: Levothyroxine for Gestational Hypothyroidism in Recurrent Pregnancy Loss
Levothyroxin, Placebo - Abortion, Habitual
Phase 3Not yet recruitingWomen's Hospital School Of Medicine Zhejiang University2002025-06-012025-06-04
Levothyroxine Treatment on Cardiac Function in Children With Subclinical Hypothyroidism
L-thyroxine - Levothyroxine, Cardiac Function
Not applicableRecruitingTanta University402025-05-242026-02-06
Novel Approaches to the Treatment of Hypothyroidism
Levothyroxine, Levothyroxine/Liothyronine once daily, Levothyroxine/Liothyronine twice daily - Hypothyroidism
Phase 2 / Phase 3RecruitingUConn Health902024-12-102026-03-19
Role of Levothyroxine Supplementation in Delayed Recovery Following Cardiac Surgery
L-thyroxine, Placebo Oral Tablet - Cardiac Surgery Intensive Care Treatment, Delayed Recovery From Anaesthesia
Phase 3CompletedAin Shams University702024-11-302025-08-17
Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab
hydroxychloroquine and levothyroxine, Levothyroxine - Recurrent Pregnancy Loss, Euthyroid With Thyroid Antibodies
Not applicableRecruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University7962024-11-152026-09-30
Levothyroxine Intervention in Pregnant Women with TSH (2.5 MIU/L-upper Limit of Reference Range) and Negative Thyroid Peroxidase Antibody
Levothyroxine Sodium (LT4) Tablets, Placebo - Thyroid Abnormalities, Pregnant Woman
Phase 4Not yet recruitingYang ZHANG4002024-10-252024-10-23
A Study of Levothyroxine and Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-028)
Levothyroxine, Enlicitide Decanoate - Healthy
Phase 1CompletedMerck Sharp & Dohme LLC282024-07-082024-10-03
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Armour Thyroid, Levothyroxine - Hypothyroidism
Phase 2 / Phase 3Active not recruitingAbbVie27012024-04-262026-10-13

Showing 20 of 158. Sign in to see all of them.

Conditions studied

Hypothyroidism (59)  ·  Thyroid Diseases (19)  ·  Thyroid Neoplasms (9)  ·  Congenital Hypothyroidism (6)  ·  Atherosclerosis (4)  ·  Brain Death (4)  ·  Heart Failure (4)  ·  Insulin Resistance (4)  ·  Diabetes Mellitus (3)  ·  Dyslipidemias (3)  ·  Endocrine System Diseases (3)  ·  Euthyroid Sick Syndromes (3)  ·  Goiter (3)  ·  Graves Disease (3)  ·  Hypopituitarism (3)

Sponsors

Insel Gruppe AG, University Hospital Bern (6)  ·  Ain Shams University (4)  ·  Mylan Pharmaceuticals Inc (4)  ·  Shandong Provincial Hospital (3)  ·  University of Pennsylvania (3)  ·  Azienda USL Modena (2)  ·  Chinese Academy of Medical Sciences, Fuwai Hospital (2)  ·  Heidelberg University (2)  ·  Herlev Hospital (2)  ·  IBSA Institut Biochimique SA (2)  ·  Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (2)  ·  Newcastle-upon-Tyne Hospitals NHS Trust (2)  ·  Poznan University of Physical Education (2)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (2)  ·  University of Aarhus (2)

Countries

United States (50)  ·  China (17)  ·  Germany (9)  ·  Egypt (8)  ·  Italy (6)  ·  Switzerland (6)  ·  Denmark (5)  ·  Netherlands (4)  ·  Canada (3)  ·  France (3)  ·  Mexico (3)  ·  United Kingdom (3)  ·  Brazil (2)  ·  India (2)  ·  Poland (2)

Top investigators

Nicolas Rodondi, MD MAS (5)  ·  James D Carlson, Pharm. D. (3)  ·  Jacobijn Gussekloo, MD (2)  ·  Ahmed M Sayed, Prof. (1)  ·  Alan K Copa, Pharm. D. (1)  ·  Alex Tessnow, MD (1)  ·  Alice P Chen, M.D. (1)  ·  Andrea Kelly, MD, MSCE (1)  ·  Andrea M Isidori, MD, PhD (1)  ·  Angeliki M Stamatouli, MD (1)  ·  Anne Julie Frenette, M.Sc (1)

Results publications

PMID 31702015, PMID 35381390, PMID 36721961, PMID 11172193, PMID 11580992, PMID 14749496, PMID 15247962, PMID 16205094, PMID 16275864, PMID 16984248, PMID 17433800, PMID 17711927, PMID 17932107, PMID 17964598, PMID 18407156, PMID 19581264, PMID 19682539, PMID 20427509, PMID 20447070, PMID 20463094, PMID 21190974, PMID 21411559, PMID 21424182, PMID 21568669, PMID 21586104, PMID 21765997, PMID 21865366, PMID 22134702, PMID 23124142, PMID 23264396, PMID 23448784, PMID 23585666, PMID 23773982, PMID 23884915, PMID 24157158, PMID 24345793, PMID 24423358, PMID 24951271, PMID 24969506, PMID 25036648, PMID 26700485, PMID 27338133, PMID 27766119, PMID 28158982, PMID 28249134, PMID 28402245, PMID 28460140, PMID 28473851, PMID 28548569, PMID 28853052

NIH funding

2015 (2), 2005 (1), 2014 (1), 2017 (1), I01CX002436 (1), K24AG042765 (1), R01AG081698 (1), R01DK137207 (1), R01HD071981 (1), R03DK114642 (1), R21DK122310 (1), R21NS095723 (1), U10HD021410 (1), U10HD027860 (1), U10HD027869 (1)